Alivira’s global presence spans across API’s and Finished dosage form
                                                   I
n the US, its API’s business is commercialized with a portfolio of 18 API filings


API’s

Alivira’s USFDA approved facility at Vizag, India has state-of-the-art infrastructure, people and equipment. Alivira has a strong commitment to providing its customers with quality products and services with robust EHS compliance.

The facility is one of its kind being India’s only dedicated veterinary API facility to secure USFDA approval first in Dec 2016 and reinspection thereafter.

It’s commitment to Environment and the Safety of its employees is validated by the fact that the facility has successfully undergone several customer audits, including the Global Top 10 Animal Health companies,covering both cGMP and EHS areas.

CDMO

Alivira’s comprehensive integrated capabilities starting from process & analytical development, stability studies & R&D capabilities till formulation development and process engineering makes it a leading partner of choice for Global Contract Research & Development, Testing and Manufacturing Services for the Animal Health Industry.

Our customer orientation differentiates itself by adopting a dedicated project management approach for supply of API’s thus delivering the desired technical and quality solutions to our customers in a timely and value-added manner. We are committed to working with our existing & new customers on ensuring they receive products of the highest quality and being responsive & customized to our customer’s requirements.

Alivira comprehensive offering of quality products, strong cGMP, EHS compliance and customer centric approach focusses on fulfilling the needs of the customers, generic new product development as well as source change of API.

Key Highlights

 

  • 1st Indian company with dedicated Veterinary API plant to secure US FDA approval
     
  • Highest Veterinary Master File (VMF) filing by a single generic company – 18 filings
     
  • Strong Porfolio of Anthelmintics, Anti-Protozoals & NSAID’s

USA API Product Portfolio 

Anthelmintics


Albendazole


Clorsulon


Closantel Sodium


Febantel


Fenbendazole


Oxfendazole


Praziquantel*


Triclabendazole

NSAID/Anesthetics


Carprofen


Deracoxib


Flunixin Meglumine*


Firocoxib


Robenacoxib

Antiprotozoal


Toltrazuril


Diclazuril


Ponazuril

Phosphorus Supplement

Butaphosphan

Analgesic

Xylazine HCL

*Health Canada Filed

For complete API list please click here

For further details and enquiries, please contact our US office :

Mr. Alan Kelly
Business Head - USA

E-Mail: alan.kelly@alivira.ie
Phone: ++ 1 630 6050080